HZNP - Horizon Therapeutics Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,207,5701,056,231981,120757,044
Cost of Revenue405,005418,183320,864208,007
Gross Profit802,565638,048660,256549,037
Operating Expenses
Research Development82,76265,79160,70741,865
Selling General and Administrative693,385655,893603,648438,405
Non Recurring----
Others----
Total Operating Expenses1,181,1521,139,867985,219688,277
Operating Income or Loss26,418-83,636-4,09968,767
Income from Continuing Operations
Total Other Income/Expenses Net-145,564-420,698-222,715-201,479
Earnings Before Interest and Taxes26,418-83,636-4,09968,767
Interest Expense-121,692-126,523-86,610-69,900
Income Before Tax-119,146-504,334-226,814-132,712
Income Tax Expense-44,959-102,749-61,251-172,244
Minority Interest----
Net Income From Continuing Ops-74,187-401,585-165,56339,532
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-74,187-401,585-165,56339,532
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-74,187-401,585-165,56339,532